Citing Strong Growth in miRNA Market, Invitrogen To Launch Updated Version of NCode Array in Q3 | GenomeWeb

Eight months after Invitrogen took interest in the microRNA array market by launching its NCode multi-species miRNA microarray platform, the company plans to release an updated version of the tool before the end of September.

The new chips are being made available to supply what the company calls "strong growth" in the market for miRNA arrays.

Peter Joszi, senior product manager of epigenetics at Invitrogen, told BioArray News last week that NCode version 2.0 would most likely be launched within three months.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.